The manufacture, use and disposal of nanomaterials will result in increased human
exposures to engineered nanoparticles (ENPs), potentially via the lung. ENPs differ …

Lung cancer is a global health problem affecting millions of people each year. Non-small
cell lung cancer (NSCLC) is the most common form of lung cancer with various conventional …

Drug delivery to the lungs by inhalation offers a targeted drug therapy for respiratory
diseases. However, the therapeutic efficacy of inhaled drugs is limited by their rapid …

The use of colloidal carrier systems for pulmonary drug delivery is an emerging field of
interest in nanomedicine. The objective of this study was to compare the pulmonary …

Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with
few systemic side effects. In addition, it is non-invasive and has good patient compliance …

Pulmonary drug delivery has drawn great attention due to its targeted local lung action,
reduced side effects, and ease of administration. However, inhaled nanoparticles (NPs) …

Abstract According to the World Health Organization (WHO), hundreds of millions of people
of all ages and in all countries suffer from chronic respiratory diseases, with particular …

The ability to manipulate the size and surface properties of nanomaterials makes them a
promising vector for improving drug delivery and efficacy. Inhalation is a desirable route of …

The purpose of this review is to discuss the impact of nanocarriers administered by
pulmonary route to treat and to diagnose respiratory and non respiratory diseases. Indeed …

Background: Aerosol therapy using particulate drug carriers has become an increasingly
attractive method to deliver therapeutic or diagnostic compounds to the lung. Polymeric …